UNICREDIT BANK/PUT/GSK PLC/1500/1/18.09.24 Share Price

Warrant

DE000HC9M3A6

Real-time BOERSE MUENCHEN 05:16:57 03/06/2024 pm IST
0.5 EUR +117.39% Intraday chart for UNICREDIT BANK/PUT/GSK PLC/1500/1/18.09.24
1 month-45.24%
3 months-55.77%
Date Price Change
03/24/03 0.5 +117.39%
31/24/31 0.23 -4.17%
30/24/30 0.24 0.00%
29/24/29 0.24 0.00%
28/24/28 0.24 +14.29%

Real-time BOERSE MUENCHEN

Last update June 03, 2024 at 05:16 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying GSK PLC
IssuerLogo Issuer UniCredit UniCredit
WKN HC9M3A
ISINDE000HC9M3A6
Date issued 02/10/2023
Strike 1,500 p
Maturity 18/09/2024 (107 Days)
Parity 1 : 1
Emission price 1.36
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2
Lowest since issue 0.17
Delta-0.28x
Omega 10.30
Premium8.85x
Gearing37.16x
Moneyness 0.9384
Difference Strike -108.5 p
Difference Strike %-7.23%
Spread 0.01
Spread %1.96%
Theoretical value 0.5050
Implied Volatility 27.36 %
Total Loss Probability 68.03 %
Intrinsic value 0.000000
Present value 0.5050
Break even 1,456.98 €
Theta-0.03x
Vega0.03x
Rho-0.01x

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
17.66 GBP
Average target price
20.26 GBP
Spread / Average Target
+14.69%
Consensus